Today: 30 April 2026
Browse Category

NSE:LTIMINDTREE 21 January 2026

Sensex, Nifty hit three-month lows again as rupee sinks to a record — what to watch next

Sensex, Nifty hit three-month lows again as rupee sinks to a record — what to watch next

Indian stocks fell Wednesday, with the Nifty 50 down 0.3% and Sensex off 0.33%, as foreign investors sold $3.23 billion in January. The rupee hit a record low of 91.7425 per dollar. HDFC Bank dropped to a nine-month low, while Reliance Industries and ICICI Bank slid after weak earnings. Ola Electric named Deepak Rastogi CFO and cut its 2026 revenue forecast.
21 January 2026
······

Stock Market Today

  • Big Tech Earnings, Fed Chair Powell's Plans, Iran Tensions Impact Oil Prices
    April 30, 2026, 9:13 AM EDT. Big Tech earnings from four of the Magnificent Seven firms beat expectations, but stocks showed mixed reactions amid growing AI investment plans. The Federal Reserve paused interest rate hikes in a rare 1992-level divided vote, with Chair Jerome Powell signaling he will remain as a governor post-chairmanship amid a Justice Department probe. Powell's potential successor, Kevin Warsh, cleared a Senate committee, suggesting policy shifts could follow. Meanwhile, oil prices surged to $126 a barrel due to escalating tensions around the Strait of Hormuz, with President Trump maintaining a U.S. blockade linked to nuclear negotiations with Iran. These developments are shaping investor sentiment and market direction on Thursday.

Latest article

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Go toTop